Therapeutic Asset Ratings

6,299 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Baff-R Car-T Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Institute of Hematology & Blood Diseases Hospital, China	P1/2	CC (45)
Baff-R Car-T Follicular Lymphoma	Institute of Hematology & Blood Diseases Hospital, China	P1/2	CC (45)
Baff-R Car-T Mantle Cell Lymphoma	Institute of Hematology & Blood Diseases Hospital, China	P1/2	CC (45)
Baff-R Car-T Marginal Zone Lymphoma	Institute of Hematology & Blood Diseases Hospital, China	P1/2	CC (45)
Baff-R Car-T Waldenstrom Macroglobulinemia	Institute of Hematology & Blood Diseases Hospital, China	P1/2	CC (45)
bat1308 Cancer	Bio-Thera Solutions	P1/2	CC (45)
bat8008 Cancer	Bio-Thera Solutions	P1/2	CC (45)
be-101 Hemophilia B	Be Biopharma	P1/2	CC (45)
Belantamab Mafodotin Hematologic Disorder	Hellenic Society of Hematology	P1/2	CC (45)
Benzoic Acid, 4-((4-Amino-3-(4-Cyclohexyl-1-Piperazinyl)-9,10-Dihydro-9,10-Dioxo-1-Anthracenyl)Amino)- Adenoid Cystic Carcinoma	VM Oncology, LLC	P1/2	CC (45)
Benzoic Acid, 4-((4-Amino-3-(4-Cyclohexyl-1-Piperazinyl)-9,10-Dihydro-9,10-Dioxo-1-Anthracenyl)Amino)- Laryngeal Carcinoma	VM Oncology, LLC	P1/2	CC (45)
Benzoic Acid, 4-((4-Amino-3-(4-Cyclohexyl-1-Piperazinyl)-9,10-Dihydro-9,10-Dioxo-1-Anthracenyl)Amino)- Lip Cancer	VM Oncology, LLC	P1/2	CC (45)
Benzoic Acid, 4-((4-Amino-3-(4-Cyclohexyl-1-Piperazinyl)-9,10-Dihydro-9,10-Dioxo-1-Anthracenyl)Amino)- Nasopharyngeal Carcinoma	VM Oncology, LLC	P1/2	CC (45)
Benzoic Acid, 4-((4-Amino-3-(4-Cyclohexyl-1-Piperazinyl)-9,10-Dihydro-9,10-Dioxo-1-Anthracenyl)Amino)- Oropharynx Cancer	VM Oncology, LLC	P1/2	CC (45)
Benzoic Acid, 4-((4-Amino-3-(4-Cyclohexyl-1-Piperazinyl)-9,10-Dihydro-9,10-Dioxo-1-Anthracenyl)Amino)- Salivary Gland Cancer	VM Oncology, LLC	P1/2	CC (45)
bg1805 Acute Myeloid Leukemia	Guangzhou Bio-gene Technology Co., Ltd	P1/2	CC (45)
bh-30643 Non-Small Cell Lung Carcinoma	BlossomHill Therapeutics	P1/2	CC (45)
bi-1808 T-Cell Non-Hodgkin Lymphoma	BioInvent International AB	P1/2	CC (45)
Bicalutamide Renal Cell Carcinoma	State University of New York at Buffalo	P1/2	CC (45)
Bifidobacterium Bifidum Hepatocellular Carcinoma	Sun Yat-sen University	P1/2	CC (45)
Biological Ntla-3001 Lung Disorder	Intellia Therapeutics	P1/2	CC (45)
bmd006 Cancer	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P1/2	CC (45)
Bms-936558-01 Head And Neck Squamous Cell Carcinoma	Bristol-Myers Squibb	P1/2	CC (45)
bn301 Diffuse Large B-Cell Lymphoma	BioNova Pharmaceuticals (Shanghai) LTD.	P1/2	CC (45)
bnt324 Lung Cancer	BioNTech SE	P1/2	CC (45)

Showing 3426 to 3450 of 6,299 assets

PreviousPage 138 of 252Next